← Back to Search

Retrospective cohort for Zenker Diverticulum (ZPOEM Trial)

N/A
Waitlist Available
Led By Prashant Kedia, MD
Research Sponsored by Methodist Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up january 2017 to december 2025
Awards & highlights

ZPOEM Trial Summary

This is a multicenter investigator-initiated trial between Baylor-Scotts & White (BSW) and Methodist Health System (MHS). This study will be conducted via a retrospective review and a prospective patient registry. Patients who have undergone the ZPOEM procedure performed by the physicians listed in this protocol will be included, as well as patients who will have this procedure in the future. Data that will be collected at MHS will be entered into an Excel spreadsheet. Patient demographic information will be collected via a review of subjects' electronic medical records. Available patient outcomes will be collected via a review of electronic medical records. This review will be conducted from 1/1/2017 through 12/31/2025.

Eligible Conditions
  • Zenker Diverticulum

ZPOEM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~january 2017 to december 2025
This trial's timeline: 3 weeks for screening, Varies for treatment, and january 2017 to december 2025 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Retrospective chart review / Compartive analyses; t-tests and Wilcoxon-Mann-Whiteney Test; Chi-square or Fisher's exact test; and Pearson correlation coeffecient or Spearman's rank-order correlation
Secondary outcome measures
Prospective follow-up of patients/ Compartive analyses; t-tests and Wilcoxon-Mann-Whiteney Test; Chi-square or Fisher's exact test; and Pearson correlation coeffecient or Spearman's rank-order correlation

ZPOEM Trial Design

2Treatment groups
Experimental Treatment
Group I: Retrospective cohortExperimental Treatment1 Intervention
Any patient of the physicians listed in this study who has undergone the ZPOEM procedure to treat ZD at Methodist Health System
Group II: Prospective cohortExperimental Treatment1 Intervention
Any patient of the physicians listed in this study who has undergone the ZPOEM procedure to treat ZD at Methodist Health System and has agreed to be follow-up post-procedure.

Find a Location

Who is running the clinical trial?

Baylor Scott and White HealthOTHER
15 Previous Clinical Trials
156,218 Total Patients Enrolled
Methodist Health SystemLead Sponsor
152 Previous Clinical Trials
4,825,595 Total Patients Enrolled
Prashant Kedia, MDPrincipal InvestigatorMethodist Health System
8 Previous Clinical Trials
1,058 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Evaluation of Peroral Endoscopic Myotomy to Treat Zenker's Diverticulum
2021. "Evaluation of Peroral Endoscopic Myotomy to Treat Zenker's Diverticulum". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05157984.
~1 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top